Explore

FDA Introduces New Safety Guidelines for Gene Editing Therapies to Accelerate Development

FDA Introduces New Safety Guidelines for Gene Editing Therapies to Accelerate Development

The FDA has released new draft safety guidelines aimed at standardizing the evaluation of genome editing therapies. These guidelines are designed to support the development of both ex vivo and in vivo gene editing products, with a focus on next-generation sequencing techniques to identify potential off-target effects. The initiative is part of the FDA's broader effort to expedite the development of personalized therapies, particularly for ultra-rare diseases. The guidelines provide a framework for nonclinical studies accompanying investigational new drug and biologics license applications, offering recommendations on sequencing strategies and sample analysis.

Johnson Johnson Targets $100 Billion Revenue Amid Regulatory Challenges

Johnson Johnson Targets $100 Billion Revenue Amid Regulatory Challenges

Johnson Johnson Targets $100 Billion Revenue Amid Regulatory Challenges

LEO Pharma's ANZUPGO Cream Receives FDA Acceptance for Treating Pediatric Hand Eczema

LEO Pharma's ANZUPGO Cream Receives FDA Acceptance for Treating Pediatric Hand Eczema

LEO Pharma has announced the FDA's acceptance of its supplemental New Drug Application for ANZUPGO® (delgocitinib) cream, aimed at treating chronic hand eczema in children aged 12-17. The application is supported by positive data from the DELTA TEEN trial, which demonstrated the cream's efficacy and safety. If approved, ANZUPGO will be the first treatment specifically indicated for pediatric patients with moderate to severe chronic hand eczema, addressing a significant unmet medical need.

Pharmaceutical Industry Embraces Continuous Manufacturing for Biologics to Enhance Supply Chain Resilience

Pharmaceutical Industry Embraces Continuous Manufacturing for Biologics to Enhance Supply Chain Resilience

Pharmaceutical Industry Embraces Continuous Manufacturing for Biologics to Enhance Supply Chain Resilience

Unapproved Weight-Loss Drug Retatrutide Gains Attention Despite FDA Status

Unapproved Weight-Loss Drug Retatrutide Gains Attention Despite FDA Status

Unapproved Weight-Loss Drug Retatrutide Gains Attention Despite FDA Status

Half Magic Launches Euphoria-Inspired Makeup Collection for Fans

Half Magic Launches Euphoria-Inspired Makeup Collection for Fans

Half Magic Launches Euphoria-Inspired Makeup Collection for Fans

FDA Demands Safety Data for Lilly's Oral GLP-1 Drug Foundayo

FDA Demands Safety Data for Lilly's Oral GLP-1 Drug Foundayo

FDA Demands Safety Data for Lilly's Oral GLP-1 Drug Foundayo

Achieve Life Sciences Completes Technology Transfer to Adare Pharma Solutions for Cytisinicline Manufacturing

Achieve Life Sciences Completes Technology Transfer to Adare Pharma Solutions for Cytisinicline Manufacturing

Achieve Life Sciences Completes Technology Transfer to Adare Pharma Solutions for Cytisinicline Manufacturing

Clear Mascara Gains Popularity for Its Versatile and Gentle Benefits

Clear Mascara Gains Popularity for Its Versatile and Gentle Benefits

Clear Mascara Gains Popularity for Its Versatile and Gentle Benefits

Red Light Therapy Gains Popularity for Beauty and Health Benefits

Red Light Therapy Gains Popularity for Beauty and Health Benefits

Red Light Therapy Gains Popularity for Beauty and Health Benefits

AI's Role in Drug Discovery: Transforming Development Strategies for Success

AI's Role in Drug Discovery: Transforming Development Strategies for Success

AI's Role in Drug Discovery: Transforming Development Strategies for Success

Charlotte Tilbury Opens First Flagship Boutique in India, Expanding Market Presence

Charlotte Tilbury Opens First Flagship Boutique in India, Expanding Market Presence

Charlotte Tilbury Opens First Flagship Boutique in India, Expanding Market Presence